Optimal drug treatment regimens for HIV depend on adherence
From MaRDI portal
Publication:2210076
DOI10.1016/J.JTBI.2006.12.038zbMATH Open1451.92170OpenAlexW2074333823WikidataQ51921692 ScholiaQ51921692MaRDI QIDQ2210076FDOQ2210076
Authors: Olga Krakovska, Lindi M. Wahl 
Publication date: 5 November 2020
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2006.12.038
Recommendations
- A mathematical model for HIV treatment with time-varying antiretroviral therapy
- A mathematical model for the emergence of HIV drug resistance during periodic bang-bang type antiretroviral treatment
- Costs versus benefits: best possible and best practical treatment regimens for HIV
- Long-term HIV dynamic models incorporating drug adherence and resistance to treatment for prediction of virological responses
- INFLUENCE OF DRUG PHARMACOKINETICS ON HIV PATHOGENESIS AND THERAPY
Cites Work
- Distinct effects of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infection with impulsive drug effects
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects
- Title not available (Why is that?)
- Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells
- Costs versus benefits: best possible and best practical treatment regimens for HIV
- Non-linear dynamics models characterizing long-term virological data from AIDS clinical trials
Cited In (14)
- Resistance to protease inhibitors in a model of HIV-1 infection with impulsive drug effects
- Global behaviour of an age-infection-structured HIV model with impulsive drug-treatment strategy
- A decrease in drug resistance levels of the HIV epidemic can be bad news
- Viral dynamics of an HIV model with pulse antiretroviral therapy and adherence
- MODELING MONOCYTE-DERIVED DENDRITIC CELLS AS A THERAPEUTIC VACCINE AGAINST HIV
- The effects of delay and impulsive drug therapy in an HIV model with CTLs immune response
- Impulsive SUI epidemic model for HIV/AIDS with chronological age and infection age
- Costs versus benefits: best possible and best practical treatment regimens for HIV
- Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting
- Modelling the effects of adherence to the HIV fusion inhibitor enfuvirtide
- Analysis of a class-age-structured HIV/AIDS model with infection-control strategies
- Effect of time delay on spatial patterns in a airal infection model with diffusion
- Modeling HIV dynamics under combination therapy with inducers and antibodies
- Dynamics of the HIV infection under antiretroviral therapy: a cellular automata approach
This page was built for publication: Optimal drug treatment regimens for HIV depend on adherence
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2210076)
